Greenphire Inc-医療機器分野:企業M&A・提携分析

◆英語タイトル:Greenphire Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011707
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:26
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Greenphire Inc (Greenphire) is a provider of clinical trial payment solutions which offers site payments and paitent reimbursement. Its product portfolio includes eClinicalGPS and ClinCard. The eClinicalGPS is a global site that facilitates accurate payment calculation, manages complex payment approval processes and automates payment execution in local currencies from sponsors and CROs to all investigators, sites and vendors involved in the clinical trial. Greenphire’s ClinCard is a joint technology platform that optimizes clinical trial performance by improving patient engagement and retention from research execution. The company offers services to medical device, bio pharmaceutical and contract research organizations. Greenphire is headquartered in King of Prussia, Pennsylvania, the US.

Greenphire Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Greenphire Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Greenphire Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Greenphire Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Greenphire Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Greenphire Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Greenphire Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Greenphire Raises US$4.3 Million In Series B Financing 10
Private Equity 11
Riverside Company Invests in Greenphire 11
Partnerships 12
Greenphire Enters Into Technology Integration Agreement With Oracle Health Sciences 12
Greenphire Enters Into Technology Integration Agreement With Merge Healthcare 13
Almac Group Enters Into Agreement With Greenphire 14
Greenphire Inc – Key Competitors 15
Greenphire Inc – Key Employees 16
Greenphire Inc – Locations And Subsidiaries 17
Head Office 17
Recent Developments 18
Corporate Communications 18
May 18, 2017: Greenphire Appoints Claudine Paccio as Chief Operations Officer 18
Jan 10, 2017: Greenphire Appoints Dave Espenshade as Vice President, Contract Research Organization Partnerships 19
Mar 10, 2016: Greenphire Appoints Wayne Baker as Chief Commercial Officer 20
Product News 21
Mar 14, 2017: Greenphire Drives Global Site Adoption of Clinical Trial Payment Solutions 21
Oct 05, 2016: Greenphire Continues Commitment to Clinical Research Site Sustainability and Innovation at Global Site Solutions Summit 22
Other Significant Developments 23
Sep 06, 2017: mProve Health and Greenphire Partner to Deliver a First-of-its-Kind Patient Engagement Solution 23
Jan 24, 2017: Greenphire and Exostar Partner to Deliver Seamless, Secure Access to Clinical Research Site Payment Solution 24
Feb 02, 2016: Greenphire Sees Burgeoning Demand for its Clinical Trial Payment Solutions 25
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Tables
Greenphire Inc, Medical Equipment, Key Facts 2
Greenphire Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Greenphire Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Greenphire Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Greenphire Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Greenphire Inc, Deals By Market, 2011 to YTD 2017 8
Greenphire Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Greenphire Raises US$4.3 Million In Series B Financing 10
Riverside Company Invests in Greenphire 11
Greenphire Enters Into Technology Integration Agreement With Oracle Health Sciences 12
Greenphire Enters Into Technology Integration Agreement With Merge Healthcare 13
Almac Group Enters Into Agreement With Greenphire 14
Greenphire Inc, Key Competitors 15
Greenphire Inc, Key Employees 16

★海外企業調査レポート[Greenphire Inc-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Cerus Corp (CERS):企業の製品パイプライン分析
    Summary Cerus Corp (Cerus) is a biomedical products company that focuses in the field of blood transfusion safety. It develops and commercializes Intercept Blood System, which reduces the risk of transfusion-transmitted infections by inactivating a wide range of pathogens including viruses, bacteria …
  • Enmax Corporation:発電所・企業SWOT分析
    Enmax Corporation – Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees ( …
  • Concur Technologies, Inc.:企業の戦略的SWOT分析
    Concur Technologies, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Volkswagen Financial Services AG:企業の戦略・SWOT・財務情報
    Volkswagen Financial Services AG - Strategy, SWOT and Corporate Finance Report Summary Volkswagen Financial Services AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Apricus Biosciences Inc (APRI):製薬・医療:M&Aディール及び事業提携情報
    Summary Apricus Biosciences Inc (Apricus) develops and commercializes pharmaceutical products indicated for the treatment of various therapeutic classes including urology and rheumatology. Its product pipeline includes, Vitaros (alprostadil), a topical vasodilator cream in-licensed from Warner Chilc …
  • Continental Grain Co:企業の戦略的SWOT分析
    Continental Grain Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Ultragenyx Pharmaceutical Inc (RARE):医療機器:M&Aディール及び事業提携情報
    Summary Ultragenyx Pharmaceutical Inc (Ultragenyx) is a biotechnology company that develops life-enhancing therapeutics for rare and ultra-rare genetic diseases. Its only marketed product, Mepsevii (vestronidase alfa) is the first indication approved for the treatment of adults and children with Muc …
  • South Jersey Industries, Inc. (SJI):石油・ガス:M&Aディール及び事業提携情報
    Summary South Jersey Industries Inc (SJI) is an energy services holding company that sources and supplies natural gas and electricity. It develops, owns, and operates on-site energy production facilities. The company provides wholesale commodity marketing and fuel management services; and also offer …
  • ABM Industries Incorporated (ABM):企業の財務・戦略的SWOT分析
    ABM Industries Incorporated (ABM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Magnolia Petroleum Plc (MAGP):企業の財務・戦略的SWOT分析
    Summary Magnolia Petroleum Plc (Magnolia Petroleum) is an oil and gas company. The company explores, acquires, and develops oil and natural gas properties. It holds interests in producing properties in two project areas such as Bakken shale in North Dakota and the proven Mississippi Lime, Woodford a …
  • Sunquest Information Systems, Inc.-医療機器分野:企業M&A・提携分析
    Summary Sunquest Information Systems, Inc. (Sunquest), a subsidiary of Roper Industries, is a healthcare information technology (IT) company that provides diagnostic informatics solutions to laboratories and healthcare organizations worldwide. The company offers laboratory information system that au …
  • Nuevolution AB (NUE):製薬・医療:M&Aディール及び事業提携情報
    Summary Nuevolution AB (Nuevolution) is a biopharmaceutical company focused on developing drug treatments for cancer and chronic inflammatory diseases. The company’s pipeline products include RORyt inhibitor, BRD (BD1), cytokine X, RORyt agonist, and GRP78. Its products are used for various indicati …
  • Unit Corp (UNT):企業の財務・戦略的SWOT分析
    Summary Unit Corp (Unit) is a diversified energy company that offers exploration and production of oil and natural gas. The company offers acquisition of producing oil and natural gas properties, contract drilling of onshore oil and natural gas wells, and gathering and processing of natural gas. It …
  • Genomind Inc-医療機器分野:企業M&A・提携分析
    Summary Genomind Inc (Genomind) is a personalized medicine company that provides genetic testing products. The company’s product portfolio includes The Genecept Assay, a genetic test developed for clinicians to optimize treatment decisions for their patients with mental illness. Its assay finds pati …
  • Bioverativ Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Bioverativ Inc (Bioverativ) is a biotechnology company that discovers, develops, and markets therapeutics for the treatment of hemophilia, and rare blood disorders. Its product portfolio includes Eloctate, which comprises recombinant antihemophilic factor engineered using Fc fusion technolog …
  • GENTEX Corp:企業の戦略的SWOT分析
    GENTEX Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Transgene Biotek Ltd (526139):企業の財務・戦略的SWOT分析
    Summary Transgene Biotek Ltd (Transgene) is a biotechnology company that develops and commercializes bio-generic drugs and vaccines to treat autoimmune diseases and cancer. The company’s product portfolio includes TrabiDHA, a vegetarian source of DHA (Docosahexaenoic acid), used to manufacture healt …
  • Option Care Enterprises Inc:企業の戦略的SWOT分析
    Option Care Enterprises Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Roust Corporation:企業の戦略・SWOT・財務情報
    Roust Corporation - Strategy, SWOT and Corporate Finance Report Summary Roust Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Enterome Bioscience SA:医療機器:M&Aディール及び事業提携情報
    Summary Enterome Bioscience SA (Enterome) is a drug development company which develops medical tests, and companion diagnostics to develop the management of microbiome-related diseases. The company develops medical tests based on its metagenotype technology platform that helps to identify microbiome …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆